beta-lactams has been researched along with Complications of Diabetes Mellitus in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CM; Chen, PL; Ko, NY; Ko, WC; Lee, CC; Lee, HC; Lee, NY; Shih, HI; Wang, LR; Wu, CJ; Yan, JJ | 1 |
Acuña, C; Gobernado, M | 1 |
Pedersen, HB; Rosborg, J | 1 |
Bogomolova, NS; Bol'shakov, LV; Drachennikova, AA | 1 |
1 review(s) available for beta-lactams and Complications of Diabetes Mellitus
Article | Year |
---|---|
[Ertapenem].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Cell Wall; Child; Diabetes Complications; Double-Blind Method; Drug Costs; Drug Synergism; Ertapenem; Female; Humans; Male; Obesity; Pregnancy; Randomized Controlled Trials as Topic; Tissue Distribution | 2007 |
3 other study(ies) available for beta-lactams and Complications of Diabetes Mellitus
Article | Year |
---|---|
Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Diabetes Complications; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Osteomyelitis; Pyomyositis; Recurrence; Salvage Therapy; Tigecycline; Treatment Outcome | 2010 |
Necrotizing external otitis: aminoglycoside and beta-lactam antibiotic treatment combined with surgical treatment.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Debridement; Diabetes Complications; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Necrosis; Otitis Externa; Pseudomonas Infections; Recurrence; Retrospective Studies; Time Factors | 1997 |
[Efficacy of a combination of dioxidine with beta-lactam antibiotics in the prevention and treatment of purulent-inflammatory complications].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbon Dioxide; Diabetes Complications; Drug Therapy, Combination; Humans; Inflammation; Necrosis; Oxidation-Reduction; Oxygen; Partial Pressure; Quinoxalines; Suppuration | 1990 |